Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pierre Coste"'
Autor:
Patrick Goldstein, Khalife Khalife, Loic Belle, Tabassome Simon, Nicolas Danchin, Francois Schiele, Philippe Gabriel Steg, Jean Fajadet, Pierre Coste, Etienne Puymirat, Yves Cottin, Jean Ferrières
Publikováno v:
Circulation. 129:1629-1636
Background— Although primary percutaneous coronary intervention (pPCI) is the preferred reperfusion method for ST-segment–elevation myocardial infarction, it remains difficult to implement in many areas, and fibrinolytic therapy is still widely u
Autor:
Alain Furber, Michel Slama, Pierre Coste, Jean-Luc Dubois-Randé, Jean-Pierre Monassier, Dominique Le Guludec, Marc Faraggi, Antoine Lafont, Patrick Dupouy, Laurent J. Feldman, P. Gabriel Steg, Christophe Tron
Publikováno v:
Circulation. 107:2684-2689
Background— Incomplete ST-segment resolution (STR) after successful primary angioplasty for acute myocardial infarction (AMI) is associated with a poor prognosis. We used intracoronary Doppler velocimetry to investigate whether incomplete STR after
Autor:
Martine Gilard, Elodie Drouet, Thierry Lefèvre, Michel Hanssen, Geneviève Mulak, Hervé Lardoux, Laurent Bonello, Céline Verstuyft, Nicolas Danchin, Vincent Bataille, Jean Ferrières, Didier Blanchard, Philippe Gabriel Steg, Tabassome Simon, Pierre Coste
Publikováno v:
Circulation
Circulation, American Heart Association, 2011, 123 (5), pp.474-82. ⟨10.1161/CIRCULATIONAHA.110.965640⟩
Circulation, American Heart Association, 2011, 123 (5), pp.474-82. ⟨10.1161/CIRCULATIONAHA.110.965640⟩
Background— Clopidogrel requires metabolic activation by cytochrome P450 2C19 (CYP2C19). Proton pump inhibitors (PPIs) that inhibit CYP2C19 are commonly coadministered with clopidogrel to reduce the risk of gastrointestinal bleeding. This analysis
Autor:
Gilbert Kirkorian, Pierre Coste, Yves Cottin, Philippe Sans, Jean-Pierre Cambou, Jacques Puel, Jean Ferrières, Pascal Gueret, Tabassome Simon, Philippe Asseman, Philippe-Gabriel Steg, Khalife Khalife, Hélène Eltchaninoff, Bernard Charbonnier, Didier Blanchard, Michael Angioi, Nicolas Danchin, Patrick Goldstein, Loic Belle, Bernard Ritz
Publikováno v:
Circulation. 118(3)
Background— Intravenous thrombolysis remains a widely used treatment for ST-elevation myocardial infarction; however, it carries a higher risk of reinfarction than primary PCI (PPCI). There are few data comparing PPCI with thrombolysis followed by
Autor:
Philippe Commeau, Thierry Lefèvre, Marie-Claude Morice, Hélène Eltchaninoff, Pierre Coste, Luc Maillard, Khalife Khalife, René Koning, Marc Bedossa, Philippe Guyon, Martine Gilard, Janusz Lipiecki, Alain Cribier, Jacques Puel, Philippe Brunel
Publikováno v:
Circulation. 104(14)
Background Stenting has been demonstrated to be superior to balloon angioplasty in de novo focal lesions located in large native vessels. However, in small vessels, the benefit of stenting remains questionable. Methods and Results A total of 381 symp
Autor:
Amadeo Betriu, Helmut D. Glogar, Jacques Puel, Rein Melkert, Patrick W. Serruys, Berthold Höfling, Hans Bonnier, Rüdiger Simon, Pierre Coste, William Wijns, Ricardo Seabra-Gomes, Wolfgang Rutsch, Javier Goicolea, Hugo A. Katus, Eline Montauban van Swijndregt, Ulrike Hauf-Zachariou, David P. Foley
Publikováno v:
Circulation. 101(13)
Background —In addition to its known properties as a competitive, nonselective β and α-1 receptor blocker, carvedilol directly inhibits vascular myocyte migration and proliferation and exerts antioxidant effects that are considerably greater than